SCHEMBL9636052

SCHEMBL9636052

CC(=O)OC(=O)c1ccccc1O.[AlH3]

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.62
TSHR P16473 2/20 0.62
HPGD P15428 7/20 0.53
HSD17B10 Q99714 4/20 0.53
ALOX15 P16050 2/20 0.53
TDP1 Q9NUW8 2/20 0.52
ALDH1A1 P00352 6/20 0.49
KDM4E B2RXH2 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
HMGB1 P09429 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
NAPRT Q6XQN6 1/20 0.48
CA14 Q9ULX7 1/20 0.48
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9636042 1.00 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL285141 0.98 LMNA (0.64) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL162390 0.96 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL7761593 0.96 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL13570450 0.96 TSHR (0.62) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL7761655 0.96 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL11337153 0.96 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15
Hydrochloric Acid SCHEMBL11262444 0.96 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL6245920 0.96 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL28461971 0.96 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3197429-A None JP disclosed
WO-2020025825-A1 INJECTABLE SOLUTION HAVING PH 7 AND COMPRISING HUMAN GLUCAGON, AT LEAST ONE IONIC SPECIES, AND AN AMPHIPHILIC COMPOUND BEARING HYDROPHOBIC RADICALS ADOCIA (FR) 2020-02-06 WO disclosed
US-5128334-A Side effect reduction, ascorbic acid or derivative IMMUNO JAPAN INC. (JP) 1992-07-07 US disclosed
JP-H03197429-A ANALGESIC AND ANTIINFLAMMATORY DRUG NAKAMURA TETSUO 1991-08-28 JP disclosed
EP-0437083-A1 Analgesic and anti-inflammatory medicine IMMUNO JAPAN INC. (JP) 1991-07-17 EP disclosed